1. Home
  2. ENTX vs MAMO Comparison

ENTX vs MAMO Comparison

Compare ENTX & MAMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • MAMO
  • Stock Information
  • Founded
  • ENTX 2010
  • MAMO 2008
  • Country
  • ENTX Israel
  • MAMO United States
  • Employees
  • ENTX N/A
  • MAMO N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • MAMO
  • Sector
  • ENTX Health Care
  • MAMO
  • Exchange
  • ENTX Nasdaq
  • MAMO NYSE
  • Market Cap
  • ENTX 104.0M
  • MAMO 91.0M
  • IPO Year
  • ENTX 2018
  • MAMO 2024
  • Fundamental
  • Price
  • ENTX $1.98
  • MAMO $2.09
  • Analyst Decision
  • ENTX Strong Buy
  • MAMO
  • Analyst Count
  • ENTX 1
  • MAMO 0
  • Target Price
  • ENTX $10.00
  • MAMO N/A
  • AVG Volume (30 Days)
  • ENTX 43.1K
  • MAMO 3.6K
  • Earning Date
  • ENTX 08-08-2025
  • MAMO 08-11-2025
  • Dividend Yield
  • ENTX N/A
  • MAMO N/A
  • EPS Growth
  • ENTX N/A
  • MAMO N/A
  • EPS
  • ENTX N/A
  • MAMO N/A
  • Revenue
  • ENTX $223,000.00
  • MAMO $95,959,187.00
  • Revenue This Year
  • ENTX N/A
  • MAMO N/A
  • Revenue Next Year
  • ENTX N/A
  • MAMO N/A
  • P/E Ratio
  • ENTX N/A
  • MAMO N/A
  • Revenue Growth
  • ENTX N/A
  • MAMO N/A
  • 52 Week Low
  • ENTX $1.41
  • MAMO $1.84
  • 52 Week High
  • ENTX $2.79
  • MAMO $4.66
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 48.00
  • MAMO N/A
  • Support Level
  • ENTX $1.87
  • MAMO N/A
  • Resistance Level
  • ENTX $2.18
  • MAMO N/A
  • Average True Range (ATR)
  • ENTX 0.18
  • MAMO 0.00
  • MACD
  • ENTX -0.00
  • MAMO 0.00
  • Stochastic Oscillator
  • ENTX 31.82
  • MAMO 0.00

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About MAMO MASSIMO GROUP

Massimo Group is engaged in the mid-tier band the (Mid-Tier Band) of the Powersports Vehicles and Boats Industry. It manufacture, import and distribute a diversified portfolio of products divided into two main lines: a motor sports brand consisting of utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), motorcycles, scooters, golf carts, and a juvenile line from go karts to balance bikes; and a motor boat line consisting of pontoon and tritoon boats (Pontoon Boats).

Share on Social Networks: